Cargando…
Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea
Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime sleepiness, impairs quality-of-life, and increases cardiovascular disease and road traffic accident risks. Continuous positive airway pressure (CPAP) treatment and mandibular advancement devices (MAD) have been shown to be effective...
Autores principales: | Sharples, Linda D., Clutterbuck-James, Abigail L., Glover, Matthew J., Bennett, Maxine S., Chadwick, Rebecca, Pittman, Marcus A., Quinnell, Timothy G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378304/ https://www.ncbi.nlm.nih.gov/pubmed/26163056 http://dx.doi.org/10.1016/j.smrv.2015.05.003 |
Ejemplares similares
-
Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome
por: Riha, Renata L.
Publicado: (2019) -
Effect of mandibular advancement device on the stomatognathic system in patients with mild‐to‐moderate obstructive sleep apnoea‐hypopnoea syndrome
por: Zhou, Jing, et al.
Publicado: (2020) -
Obstructive sleep apnoea/hypopnoea syndrome in adults with Down syndrome
por: Hill, Elizabeth A.
Publicado: (2016) -
Altered clot microstructure detected in obstructive sleep apnoea hypopnoea syndrome
por: D׳Silva, Lindsay, et al.
Publicado: (2016) -
Obstructive sleep apnoea/hypopnoea syndrome: relationship with obesity and management in obese patients
por: Salzano, Giovanni, et al.
Publicado: (2021)